Liquid Biopsy Market Analysis: Next-Generation Sequencing, Circulating Biomarkers, and Non-Invasive Cancer Diagnostics

Non-invasive cancer detection (NICD) using blood-based biomarker analysis has transformed oncology research and clinical staging. The Liquid Biopsy Market relies on isolating circulating tumor DNA (ctDNA), cell-free DNA (cfDNA), circulating tumor cells (CTCs), and extracellular vesicles to evaluate tumor genomics, track minimal residual disease (MRD), and detect therapeutic resistance mutations in real time. Accordin